Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab

Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):499-501. doi: 10.1177/039463201202500220.

Abstract

Anti-TNF drugs may be associated with various adverse reactions including cutaneous ones. We describe the case of a 45-year-old woman affected by undifferentiated spondyloarthritis who presented a localized psoriasiformis dermatitis during treatment with adalimumab, without any medical history of psoriasis.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Biopsy
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Female
  • Humans
  • Middle Aged
  • Psoriasis / chemically induced*
  • Psoriasis / pathology
  • Skin / drug effects*
  • Skin / pathology
  • Spondylarthropathies / drug therapy*
  • Spondylarthropathies / immunology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Adalimumab